Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
J Antimicrob Chemother. 1996 Sep;38(3):523-37. doi: 10.1093/jac/38.3.523.
J Antimicrob Chemother. 1996.
PMID: 8889726
Clinical Trial.
Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem.
Norrby SR, Newell PA, Faulkner KL, Lesky W.
Norrby SR, et al. Among authors: faulkner kl.
J Antimicrob Chemother. 1995 Jul;36 Suppl A:207-23. doi: 10.1093/jac/36.suppl_a.207.
J Antimicrob Chemother. 1995.
PMID: 8543496
Clinical Trial.
Item in Clipboard
A compilation of meropenem tissue distribution data.
Hutchison M, Faulkner KL, Turner PJ, Haworth SJ, Sheikh W, Nadler H, Pitkin DH.
Hutchison M, et al. Among authors: faulkner kl.
J Antimicrob Chemother. 1995 Jul;36 Suppl A:43-56. doi: 10.1093/jac/36.suppl_a.43.
J Antimicrob Chemother. 1995.
PMID: 8543498
Item in Clipboard
Efficacy, safety and tolerability of meropenem as empiric antibiotic therapy in hospitalized pediatric patients.
Bradley JS, Faulkner KL, Klaugman KP.
Bradley JS, et al. Among authors: faulkner kl.
Pediatr Infect Dis J. 1996 Aug;15(8):749-57. doi: 10.1097/00006454-199608000-00037.
Pediatr Infect Dis J. 1996.
PMID: 8858694
Review.
No abstract available.
Item in Clipboard
Overview of the tolerability of gefitinib (IRESSA) monotherapy : clinical experience in non-small-cell lung cancer.
Forsythe B, Faulkner K.
Forsythe B, et al.
Drug Saf. 2004;27(14):1081-92. doi: 10.2165/00002018-200427140-00002.
Drug Saf. 2004.
PMID: 15554744
Review.
Item in Clipboard
Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Phase I and II clinical trials.
Tullo AB, Esmaeli B, Murray PI, Bristow E, Forsythe BJ, Faulkner K.
Tullo AB, et al.
Eye (Lond). 2005 Jul;19(7):729-38. doi: 10.1038/sj.eye.6701630.
Eye (Lond). 2005.
PMID: 15688060
Clinical Trial.
Item in Clipboard
Cite
Cite